| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | Pierce Christopher | EVP and Chief of Business Oper | Sep 02, 2021 | Option Exercise | $12.85 | 17,000 | 218,450 | 20,750 | Sep 07, 2021, 07:17 PM | |
| PRLD | Prelude Therapeutics Inc | Pierce Christopher | EVP and Chief of Business Oper | Sep 02, 2021 | Sale | $41.68 | 17,000 | 708,493 | 17,407 | Sep 07, 2021, 07:17 PM | |
| PRLD | Prelude Therapeutics Inc | Pierce Christopher | EVP and Chief of Business Oper | Apr 29, 2021 | Option Exercise | $1.89 | 3,295 | 6,228 | 7,045 | Apr 30, 2021, 06:24 PM | |
| PRLD | Prelude Therapeutics Inc | Pierce Christopher | EVP and Chief of Business Oper | Apr 29, 2021 | Sale | $40.29 | 3,295 | 132,765 | 3,750 | Apr 30, 2021, 06:24 PM | |
| PRLD | Prelude Therapeutics Inc | Pierce Christopher | EVP and Chief of Business Oper | Apr 08, 2021 | Option Exercise | $1.89 | 200 | 378 | 3,950 | Apr 15, 2021, 07:12 PM | |
| PRLD | Prelude Therapeutics Inc | Pierce Christopher | EVP and Chief of Business Oper | Apr 08, 2021 | Sale | $40.00 | 200 | 8,000 | 3,750 | Apr 15, 2021, 07:12 PM | |
| PRLD | Prelude Therapeutics Inc | Pierce Christopher | EVP and Chief of Business Oper | Apr 07, 2021 | Option Exercise | $1.89 | 828 | 1,565 | 4,578 | Apr 09, 2021, 05:53 PM | |
| PRLD | Prelude Therapeutics Inc | Pierce Christopher | EVP and Chief of Business Oper | Apr 07, 2021 | Sale | $40.08 | 828 | 33,188 | 3,750 | Apr 09, 2021, 05:53 PM | |
| PRLD | Prelude Therapeutics Inc | Pierce Christopher | EVP and Chief of Business Oper | Sep 29, 2020 | Buy | $19.00 | 3,750 | 71,250 | 3,750 | Sep 29, 2020, 08:07 PM |
Menu